Cargando…
Novel SPAST deletion and reduced DPY30 expression in a Spastic Paraplegia type 4 kindred
BACKGROUND: The hereditary spastic paraplegias (HSPs) are pleiomorphic disorders of motor pathway and a large number of affected genes have been discovered. Yet, mutations in SPG4/SPAST represent the most frequent molecular etiology in autosomal dominant (AD) patients and sporadic cases. We describe...
Autores principales: | Racis, Loretta, Storti, Eugenia, Pugliatti, Maura, Agnetti, Virgilio, Tessa, Alessandra, Santorelli, Filippo M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974227/ https://www.ncbi.nlm.nih.gov/pubmed/24690193 http://dx.doi.org/10.1186/1471-2350-15-39 |
Ejemplares similares
-
Therapeutic Strategies for Mutant SPAST-Based Hereditary Spastic Paraplegia
por: Mohan, Neha, et al.
Publicado: (2021) -
Case report on novel mutation in SPAST gene in Polish family with spastic paraplegia
por: Klimkowicz-Mrowiec, Aleksandra, et al.
Publicado: (2019) -
Reduced acetylated α-tubulin in SPAST hereditary spastic paraplegia patient PBMCs
por: Wali, Gautam, et al.
Publicado: (2023) -
A patient-derived stem cell model of hereditary spastic paraplegia with SPAST mutations
por: Abrahamsen, Greger, et al.
Publicado: (2013) -
Hereditary Spastic Paraplegia with a Novel SPAST Mutation Misdiagnosed with Subacute Combined Degeneration
por: Yang, Ji Won, et al.
Publicado: (2013)